Is prophylactic anti-convulsive treatment necessary in subdural hematomas?

Area of Science:

• Neurosurgery
• Neurology
• Clinical Medicine

Background:

• Subdural hematoma (SDH) is a critical neurosurgical condition with an unclear link to epilepsy.
• The use of anti-convulsive therapy in SDH patients remains controversial.
• This study investigates seizure occurrence in surgically treated SDH patients.

Purpose of the Study:

• To analyze the incidence of seizures in patients undergoing surgery for subdural hematoma.
• To identify factors associated with seizure development in SDH patients.

Main Methods:

• Retrospective review of 175 patients operated for SDH between 2016 and 2021.
• Evaluation of demographic data, Glasgow Coma Scale (GCS) score, SDH type and location, etiology, surgical approach, and seizure occurrence.
• Statistical analysis to determine correlations between variables and seizure development.

Main Results:

• Acute SDH was significantly associated with a higher frequency of seizures compared to other SDH types.
• Patients with a GCS score below 12 at admission experienced more seizures.
• No significant association found between seizures and SDH etiology, re-operation, or hematoma location.

Conclusions:

• Anti-convulsive treatment might be beneficial for patients with acute SDH and low GCS scores.
• Further research with larger cohorts is needed to establish optimal anti-convulsive strategies for SDH management.